ENTRY       D06463                      Drug
NAME        Lumiliximab (USAN/INN);
            Gomiliximab (USAN)
FORMULA     C6850H10656N1824O2106S50
EXACT_MASS  153764.8843
MOL_WEIGHT  153860.1108
EFFICACY    Antiallergic, Antiasthmatic, Antineoplastic, Anti-CD23 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of allergic asthma, allergic rhinitis, and chronic lymphocytic leukemia
TARGET      CD23 [HSA:2208] [KO:K06468]
  PATHWAY   hsa04640(2208)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD23
                 D06463  Lumiliximab (USAN/INN)
DBLINKS     CAS: 357613-86-6
            PubChem: 47208119
///
